The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 15, 2009

Filed:

Oct. 10, 2006
Applicants:

Kaj Albermann, Martinsried, DE;

Wolfram Kemmner, Munich, DE;

Dieter Maier, Martinsried, DE;

Fabio Spreafico, Lecco, IT;

Alexander Stock, Martinsried, DE;

Christian Wagner, Martinsried, DE;

Lex DE Boer, Wateringen, NL;

Roelf Bernhard Meima, Kamerik, NL;

Inventors:

Kaj Albermann, Martinsried, DE;

Wolfram Kemmner, Munich, DE;

Dieter Maier, Martinsried, DE;

Fabio Spreafico, Lecco, IT;

Alexander Stock, Martinsried, DE;

Christian Wagner, Martinsried, DE;

Lex De Boer, Wateringen, NL;

Roelf Bernhard Meima, Kamerik, NL;

Assignee:

DSM IP Assets B.V., Heerlen, NL;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A21D 2/00 (2006.01); C12N 9/20 (2006.01); A23C 9/12 (2006.01); C12N 1/00 (2006.01); C12N 9/16 (2006.01); C07H 21/04 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention relates to a newly identified polynucleotide sequence comprising a gene that encodes a novel phospholipase isolated from. The invention features the full length nucleotide sequence of the novel gene, the cDNA sequence comprising the full length coding sequence of the novel phospholipase as well as the amino acid sequence of the full-length functional protein and functional equivalents thereof. The invention also relates to methods of using these enzymes in industrial processes and methods of diagnosing fungal infections. Also included in the invention are cells transformed with a polynucleotide according to the invention and cells wherein a phospholipase according to the invention is genetically modified to enhance or reduce its activity and/or level of expression.


Find Patent Forward Citations

Loading…